Grassley criticizes FDA over ethics of blood substitute testing

03/14/2006 | Chicago Tribune (tiered subscription model)

Sen. Chuck Grassley, R-Iowa, says the FDA ignored for two years concerns of the Office for Human Research Protections about the risks of tests of a blood substitute without patient consent. Northfield Laboratories' trial involves giving Polyheme to trauma victims.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI